Active, not recruitingNot applicableNCT03983512

PULSTA Transcatheter Pulmonary Valve Pre-Approval Study

Studying Tetralogy of Fallot

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Taewoong Medical Co., Ltd.
Principal Investigator
Mario Carminati, PhD. MD.
Policlinico San Donato
Intervention
PULSTA TPV System(device)
Enrollment
58 enrolled
Eligibility
10 years · All sexes
Timeline
20192022

Study locations (11)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03983512 on ClinicalTrials.gov

Other trials for Tetralogy of Fallot

Additional recruiting or active studies for the same condition.

See all trials for Tetralogy of Fallot

← Back to all trials